Role of AMP-Activated Protein Kinase Activators in Antiproliferative Multi-Drug Pituitary Tumour Therapies: Effects of Combined Treatments with Compounds Affecting the mTOR-p70S6 Kinase Axis in Cultured Pituitary Tumour Cells

GIUSTINA , ANDREA
2015-01-01

2015
AMP-activated kinase; AMPK silencing; Cell growth; P70S6 kinase; Pituitary tumour; Rapamycin; AMP-Activated Protein Kinases; Aminoimidazole Carboxamide; Animals; Antineoplastic Agents; Catalytic Domain; Cell Line; Tumor; Cell Proliferation; Down-Regulation; Enzyme Activation; Imidazoles; Phosphorylation; Piperazines; Pituitary Neoplasms; Rats; Ribonucleotides; Ribosomal Protein S6 Kinases; 70-kDa; Sirolimus; TOR Serine-Threonine Kinases; Endocrinology; Diabetes and Metabolism; Endocrine and Autonomic Systems; Cellular and Molecular Neuroscience; Medicine (all)
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/20.500.11768/15701
Citazioni
  • ???jsp.display-item.citation.pmc??? 7
  • Scopus 11
  • ???jsp.display-item.citation.isi??? 12
social impact